ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
251.35
-3.97 (-1.55%)
Mar 6, 2026, 12:22 PM EST - Market open
ResMed Analyst Ratings
Total Analysts
11
Consensus Rating
Buy
Price Target
$293.70
Upside
+16.85%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $330 → $345 | Strong Buy | Maintains | $330 → $345 | +37.26% | Feb 2, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $311 → $314 | Buy | Maintains | $311 → $314 | +24.93% | Jan 30, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $270 → $275 | Hold | Maintains | $270 → $275 | +9.41% | Jan 30, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $265 → $270 | Hold | Maintains | $265 → $270 | +7.42% | Jan 30, 2026 |
| Stifel | Stifel | Hold Maintains $260 → $265 | Hold | Maintains | $260 → $265 | +5.43% | Jan 30, 2026 |
| Stifel | Stifel | Hold Maintains $270 → $260 | Hold | Maintains | $270 → $260 | +3.44% | Dec 18, 2025 |
| Baird | Baird | Buy → Hold Downgrades $300 → $275 | Buy → Hold | Downgrades | $300 → $275 | +9.41% | Dec 16, 2025 |
| Baird | Baird | Buy Maintains $320 → $300 | Buy | Maintains | $320 → $300 | +19.36% | Nov 3, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $300 → $303 | Buy | Maintains | $300 → $303 | +20.55% | Oct 31, 2025 |
| Keybanc | Keybanc | Buy Maintains $298 → $299 | Buy | Maintains | $298 → $299 | +18.96% | Oct 31, 2025 |
| Mizuho | Mizuho | Buy Maintains $310 → $300 | Buy | Maintains | $310 → $300 | +19.36% | Oct 31, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $298 → $304 | Buy | Maintains | $298 → $304 | +20.95% | Oct 21, 2025 |
| Wells Fargo | Wells Fargo | Hold Initiates $280 | Hold | Initiates | $280 | +11.40% | Oct 13, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $330 | Strong Buy | Initiates | $330 | +31.29% | Sep 18, 2025 |
| Mizuho | Mizuho | Buy Maintains $270 → $290 | Buy | Maintains | $270 → $290 | +15.38% | Aug 1, 2025 |
| Stifel | Stifel | Hold Maintains $240 → $270 | Hold | Maintains | $240 → $270 | +7.42% | Aug 1, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.